A Study to Evaluate the Irritation Potential of ATx201 in Healthy Volunteers

Summary

This is a Phase I single-site study to evaluate the irritation potential of topically applied ATx201 GEL, 2% and 4%, along with positive and negative control and placebo control (ATx201 GEL Placebo), in healthy human subjects on intact and abraded skin. Approximately thirty-six (36) healthy adult subjects will receive all the test articles to provide for 30 subjects to complete the study. The test articles will be applied to the upper back of the subjects during the study, and the placement of the test articles will be randomized. Abraded skin will be induced using sequential tape stripping.

Timeline

Start

2017-10-04

Primary completion

2017-11-06

Completion

2017-11-06

Drugs

Indications

No indication recorded.